Latest Humanized antibody Stories
INCLINE VILLAGE, Nev., Aug. 11 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc.
BOSTON, July 1 /PRNewswire/ -- China PharmaHub Corp. ("PharmaHub"), announced today that it has entered into a definitive agreement with Dr. David Weaver and Dr. Michael Rynkiewicz. In addition, PharmaHub contemplates merging with World Wide Relics, Inc.
MISSISSAUGA, ON, June 3 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM), today announced the appointment of Dr. Nick Glover to the newly created position of President and Chief Operating Officer. Dr.
INCLINE VILLAGE, Nev., May 4 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that John P.
NEW YORK, March 24 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc.
EUREKA project E! 3424 RECAN has developed a range of unique and highly specific monoclonal and polyclonal antibodies â€“ the proteins produced in the blood which counteract bacteria, viruses or cancerous cells.
INCLINE VILLAGE, Nev., March 16 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the company will hold its annual meeting of stockholders on Wednesday, June 9, 2010 at 9:00a.m. Pacific Time for all stockholders of record on April 15, 2010.
INCLINE VILLAGE, Nev., March 3 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that John P.
How do you study-and try to cure in the laboratory-an infection that only humans can get?
LONDON, February 4 /PRNewswire/ -- A major centre created by the Medical Research Council (MRC) and MRC Technology (MRCT) in order to fast-track the discovery and development of novel drugs, opens its first call for targets today. The MRCT Centre for Therapeutics Discovery (CTD), based in London, is seeking small molecule drug discovery and therapeutic antibody targets from academic researchers. The CTD would like to collaborate with scientists in all universities to develop drug...
- To swell, as grain or wood with water.